Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427

Regulation of ferritin genes and protein

Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173

Cytochrome c release from mitochondria proceeds by a two-step process

Ott, M., Robertson, J. D., Gogvadze, V. G., Zhivotovsky, B., & Orrenius, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655498 · Cited by 955

The genetics and pathology of oxidative phosphorylation

Smeitink, J. A. M., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 733

Transcriptional regulation of erythropoiesis: an affair involving multiple partners

Cantor, A. B., & Orkin, S. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205326 · Cited by 610

Ferritin, iron homeostasis, and oxidative damage1,2 1Guest Editor: Mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

Arosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 553

Global regulation of erythroid gene expression by transcription factor GATA-1

Welch, J. J. (2004) · Blood · doi:10.1182/blood-2004-04-1603 · Cited by 427

The Mitochondrion in Cell Death Control: Certainties and Incognita

Loeffler, M. W., & Kroemer, G. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4833 · Cited by 393

Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

Maria, R. D., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S. M., Alnemri, E. S., Testa, U., & Peschle, C. (1999) · Nature · doi:10.1038/46809 · Cited by 390

Injected cytochrome c induces apoptosis

Zhivotovsky, B., Orrenius, S., Brustugun, O. T., & Døskeland, S. O. (1998) · Nature · doi:10.1038/35060 · Cited by 351

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Hellström-Lindberg, E., Ahlgren, T., Beguin, Y. P., Carlsson, M., Carneskog, J., Dahl, I. M. S., Dybedal, I., Grimfors, G., Kanter‐Lewensohn, L. R., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 303

Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation

Dibbert, B., Weber, M., Nikolaizik, W. H., Vogt, P., Schöni, M. H., Blaser, K., & Simon, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13330 · Cited by 282

Apoptotic mechanisms in the control of erythropoiesis

Testa, U. (2004) · Leukemia · doi:10.1038/sj.leu.2403383 · Cited by 236

Early Mitochondrial Activation and Cytochrome c Up-regulation during Apoptosis

Chandra, D., Liu, J.-W., & Tang, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207622200 · Cited by 217

GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages.

Iwasaki, H., Mizuno, S., Wells, R., Cantor, A., Watanabe, S., & Akashi, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00242-5 · Cited by 214

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

Barrett, J., Saunthararajah, Y., & Molldrem, J. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90027-1 · Cited by 207

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

Cazzola, M., Invernizzi, R., Bergamaschi, G., Levi, S., Corsi, B., Travaglino, E., Rolandi, V., Biasiotto, G., Drysdale, J., & Arosio, P. (2003) · Blood · doi:10.1182/blood-2002-07-2006 · Cited by 205

Hematopoietic development: a balancing act

Cantor, A. B., & Orkin, S. H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00226-4 · Cited by 191

Mitochondrial Ferritin: A New Player in Iron Metabolism

Drysdale, J., Arosio, P., Invernizzi, R., Cazzola, M., Volz, A., Corsi, B., Biasiotto, G., & Levi, S. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0577 · Cited by 180

Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis

Nie, G., Sheftel, A. D., Kim, S. F., & Ponka, P. (2004) · Blood · doi:10.1182/blood-2004-07-2722 · Cited by 180

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K., Yamashita, Y., Kaneko, T., Mori, M., Kirito, K., Toshima, M., et al. (2001) · Blood · doi:10.1182/blood.v98.2.422 · Cited by 170

Pathogenesis, etiology and epidemiology of myelodysplastic syndromes.

Aul, C., Bowen, D. T., & Yoshida, Y. (1998) · PubMed · Cited by 167

Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils

Mayanskiy, N. A., Mul, E. P. J., van Buul, J. D., Roos, D., & Kuijpers, T. W. (2002) · Blood · doi:10.1182/blood.v99.2.672 · Cited by 165

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte‐mediated inhibition of CFU‐GM and alterations in T‐cell receptor Vβ profiles

Molldrem, J. J., Jiang, Y. Z., Stetler‐Stevenson, M., Mavroudis, D., Hensel, N. F., & Barrett, A. J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00920.x · Cited by 160

Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples

Wibom, R., Hagenfeldt, L., & von Döbeln, U. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00424-4 · Cited by 148

Hypocellular myelodysplastic syndromes (MDS): new proposals

Tüzüner, N., Cox, C., Rowe, J. M., Watrous, D., & Bennett, J. M. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05356.x · Cited by 143

GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression

Chiba, T., Ikawa, Y., & Todokoro, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3843 · Cited by 140

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

Tehranchi, R., Fadeel, B., Forsblom, A., Christensson, B., Samuelsson, J., Zhivotovsky, B., & Hellström‐Lindberg, E. (2003) · Blood · doi:10.1182/blood-2002-06-1774 · Cited by 130

‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins

Parker, Fishlock, Mijovic, Czepulkowski, Pagliuca, A., & Mufti (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01114.x · Cited by 118

Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor

Mayanskiy, N. A., Roos, D., & Kuijpers, T. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7024 · Cited by 81

Erythropoietin receptor signals both proliferation and erythroid-specific differentiation.

Liboi, E., Carroll, M. P., D’Andrea, A. D., & Mathey-Prévôt, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11351 · Cited by 77

Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells

Cozzi, A., Levi, S., Corsi, B., Santambrogio, P., Campanella, A., Gerardi, G., & Arosio, P. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00114-5 · Cited by 76

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction

Fontenay, M., Bouscary, D., Guesnu, M., Picard, F., Melle, J., Lacombe, C., Gisselbrecht, S., Mayeux, P., & Dreyfus, F. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01539.x · Cited by 74

Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases

Lindberg, E. H., Schmidt‐Mende, J., Forsblom, A., Christensson, B., Fadeel, B., & Zhivotovsky, B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02581.x · Cited by 62

Refractory myelodysplastic anaemias with hypocellular bone marrow.

Yoshida, Y., Oguma, S., Uchino, H., & MAEKAWA, T. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.7.763 · Cited by 61

Increased apoptosis in acquired sideroblastic anaemia

Matthes, T., Meyer, G., Samii, K., & Beris, P. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02425.x · Cited by 41

In vitro expansion of human cord blood CD36+ erythroid progenitors: Temporal changes in gene and protein expression

Scicchitano, M. S., McFarland, D. C., Tierney, L. A., Narayanan, P. K., & Schwartz, L. W. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00185-1 · Cited by 38

Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts

Schmidt-Mende, J., Tehranchi, R., Forsblom, A., Joseph, B., Christensson, B., Fadeel, B., Zhivotovsky, B., & Hellström‐Lindberg, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402110 · Cited by 37

Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.

Backx, B., Broeders, L., Lh, H., Wognum, B., & Löwenberg, B. (1996) · PubMed · Cited by 35

Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.

Toyama, K., Ohyashiki, K., Yoshida, Y., Abe, T., Asano, S., Hirai, H., Hirashima, K., Hotta, T., Kuramoto, A., & Kuriya, S. (1993) · PubMed · Cited by 33

Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.

Ljung, T., Bäck, R., & Hellström‐Lindberg, E. (2004) · PubMed · Cited by 18

Differentiation kinetics and globin gene expression by circulating human BFUe in suspension cultures.

Umemura, T., Constantoulakis, P., Papayannopoulou, T., & Stamatoyannopoulos, G. (1990) · PubMed · Cited by 7

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222

Ferritins: A family of molecules for iron storage, antioxidation and more

Arosio, P., Ingrassia, R., & Cavadini, P. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.004 · Cited by 886

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia‐Manero, G., Buckstein, R. J., Santini, V., Díez‐Campelo, M., Finelli, C., Cazzola, M., İlhan, O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1908892 · Cited by 551

Intracellular iron transport and storage: from molecular mechanisms to health implications

Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Malcovati, L., Papaemmanuil, E., Bowen, D., Boultwood, J., Porta, M. G. D., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 506

Erythropoiesis Is Highly Stimulated in CD34+ Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Tehranchi, R., Invernizzi, R., Zhivotovsky, B., Fadeel, B., Forsblom, A., Travaglino, E., Samuelsson, J., Hast, R., Nilsson, L., Wibom, R., et al. (2004) · Blood · doi:10.1182/blood.v104.11.473.473

syndromes characterize early erythroid precursors in low-risk myelodysplastic Aberrant mitochondrial iron distribution and maturation arrest

Hellström‐Lindberg, E., Travaglino, E., Samuelsson, J., Hast, R., Nilsson, L., Cazzola, M., Invernizzi, R., Grandien, A., Zhivotovsky, B., & Fadeel, B. (2013)

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

Porta, M. G. D., Rosti, V., Gallì, A., Travaglino, E., Santambrogio, P., Marseglia, C., Matti, V., Malcovati, L., Bergamaschi, G., Levi, S., et al. (2009) · Blood · doi:10.1182/blood.v114.22.736.736 · Cited by 2

P-41 Aberrant mitochondrial iron distribution and maturation arrest characterizes early erythroid precursors in low-risk myelodysplastic syndromes

Tehranchi, R., Invernizzi, R. W., Grandien, A., Zhivotovsky, B., Fadeel, B., Forsblom, A., Travaglino, E., Samuelsson, J., Cazzola, M., Wibom, R., et al. (2005) · Leukemia Research · doi:10.1016/s0145-2126(05)80105-5 · Cited by 1

Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors

Invernizzi, R., Travaglino, E., Porta, M. G. D., Gallì, A., Malcovati, L., Rosti, V., Bergamaschi, G., Erba, B. G., Bellistri, F., Bastia, R., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12316 · Cited by 13